Weinstein Erica J, Han Jennifer H, Lautenbach Ebbing, Nachamkin Irving, Garrigan Charles, Bilker Warren B, Dankwa Lois, Wheeler Mary, Tolomeo Pam, Anesi Judith A
Division of Infectious Diseases, Department of Medicine.
Center for Clinical Epidemiology and Biostatistics.
Open Forum Infect Dis. 2019 Mar 14;6(4):ofz164. doi: 10.1093/ofid/ofz164. eCollection 2019 Apr.
Bacterial resistance to first line antibiotics used to treat community-onset urinary tract infections (UTIs) continues to increase. We sought to create a clinical prediction tool for community-onset UTIs due to extended-spectrum cephalosporin-resistant (ESC-R) Enterobacterales (formerly Enterobacteriaceae, EB).
A case-control study was performed. The source population included patients presenting to an emergency department (ED) or outpatient practice with an EB UTI between 2010 and 2013. Case patients had ESC-R EB UTIs. Control patients had ESC-susceptible EB UTIs and were matched to cases 1:1 on study year. Multivariable conditional logistic regression was performed to develop the predictive model by maximizing the area under the receiver-operating curve (AUC). Internal validation was performed via bootstrapping.
A total of 302 patients with a community-onset EB UTI were included, with 151 cases and 151 controls. After multivariable analysis, we found that presentation with an ESC-R EB community-onset UTI could be predicted by the following: (1) a history of malignancy; (2) a history of diabetes; (3) recent skilled nursing facility or hospital stay; (4) recent trimethoprim-sulfamethoxazole exposure; and (5) pyelonephritis at the time of presentation (AUC 0.73, Hosmer-Lemeshow goodness-of-fit value 0.23). With this model, each covariate confers a single point, and a patient with ≥ 2 points is considered high risk for ESC-R EB (sensitivity 80%, specificity 54%). The adjusted AUC after bootstrapping was 0.71.
Community-onset ESC-R EB UTI can be predicted using the proposed scoring system, which can help guide diagnostic and therapeutic interventions.
用于治疗社区获得性尿路感染(UTI)的一线抗生素的细菌耐药性持续上升。我们试图创建一种针对由产超广谱头孢菌素耐药(ESC-R)肠杆菌科细菌(以前称为肠杆菌科,EB)引起的社区获得性UTI的临床预测工具。
进行了一项病例对照研究。源人群包括2010年至2013年间因EB UTI就诊于急诊科(ED)或门诊的患者。病例患者患有ESC-R EB UTI。对照患者患有ESC敏感的EB UTI,并在研究年份上与病例1:1匹配。通过最大化受试者工作特征曲线(AUC)下的面积进行多变量条件逻辑回归以建立预测模型。通过自抽样进行内部验证。
总共纳入了302例社区获得性EB UTI患者,其中151例为病例,151例为对照。经过多变量分析,我们发现ESC-R EB社区获得性UTI的表现可通过以下因素预测:(1)恶性肿瘤病史;(2)糖尿病病史;(3)近期在专业护理机构或医院住院;(4)近期使用过甲氧苄啶-磺胺甲恶唑;以及(5)就诊时为肾盂肾炎(AUC 0.73,Hosmer-Lemeshow拟合优度值0.23)。使用该模型,每个协变量赋予1分,≥2分的患者被认为是ESC-R EB的高风险患者(敏感性80%,特异性54%)。自抽样后的调整AUC为0.71。
使用所提出的评分系统可以预测社区获得性ESC-R EB UTI,这有助于指导诊断和治疗干预。